US researchers just grew a beating mini human heart in a dish

WHY THIS MATTERS IN BRIEF

On the one hand being able to grow new human organs on demand will help alleviate transplant issues, on the other it will help accelerate the development and testing of new drugs and treatments.

 

Love the Exponential Future? Join our XPotential Community, enjoy exclusive content, future proof yourself with XPotential Universityconnect, watch a keynote, or browse my blog.

Recently researchers showed off their mini beating hearts in a jar, which frankly, was as freaky as it was a marvel of science, and their first mini human livers grown from stem cells, and now Michigan State University researchers have created for the first time a “miniature human heart model in the laboratory, complete with all primary heart cell types and a functioning structure of chambers and vascular tissue.” In short, we’ve gone from a stand alone beating heart in a jar to a stand alone beating heart in a lab – with no animal host anywhere to be seen.

 

READ
New regenerative bandage heals wounds four times faster

 

“These mini hearts constitute incredibly powerful models in which to study all kinds of cardiac disorders with a degree of precision unseen before,” said Aitor Aguirre, the study’s senior author and assistant professor of biomedical engineering at MSU’s Institute for Quantitative Health Science and Engineering.

This study, “Generation of Heart Organoids Modelling Early Human Cardiac Development Under Defined Conditions,” appears on the bioRxiv preprint server and was funded by grants from the American Heart Association and the National Institutes of Health where, in the US, heart disease is the number one cause of death.

The human heart organoids, or hHOs for short, were created using a novel stem cell framework, which is like the scaffolding you put up around a building, that mimics the embryonic and foetal developmental environments.

 

READ
Adidas unveils their first 3D printed mass market sneaker

 

“Organoids – meaning resembling an organ – are self-assembling 3D cell constructs that recapitulate organ properties and structure to a significant extent,” said Yonatan Israeli, a graduate student in the Aguirre Lab and first author of the study.

The experiment used a bio-engineering process that based on pluripotent stem cells – adult cells from a patient that trigger embryonic-like heart development in a dish which produced a functional mini heart in just a few weeks.

 

See the mini hearts beating

 

“This process allows the stem cells to develop, basically as they would in an embryo, into the various cell types and structures present in the heart,” Aguirre said. “We give the cells the instructions and they know what they have to do when all the appropriate conditions are met.”

Because the organoids followed the natural cardiac embryonic development process, the researchers were able to study the natural growth of an actual foetal human heart in a dish in real time – a world first.

 

READ
Scientists two headed 'Franken-Rat' paves the way for human head transplant trials

 

The technology also allows for the creation of numerous hHOs simultaneously with relative ease, contrasting with existing tissue engineering approaches that are expensive, labour intensive and not particularly scalable.

One of the primary issues facing the study of foetal heart development and congenital heart defects is access to a developing heart. So far researchers have been confined to the use of mammalian models, donated foetal remains, and in vitro cell research to approximate function and development, but now all they’ll need is a dish and some stem cells instead.

“Now we can have the best of both worlds, a precise human model to study these diseases — a tiny human heart — without using fetal material or violating ethical principles. This constitutes a great step forward,” Aguirre said.

 

READ
Jeff Bezos announces plans to create the world's first Moon delivery service

 

What’s next? For Aguirre, the process is twofold. First, the heart organoid represents an unprecedented look into the nuts and bolts of how a fetal heart develops.

“In the lab, we are currently using heart organoids to model congenital heart disease — the most common birth defect in humans affecting nearly 1% of the newborn population,” Aguirre said. “With our heart organoids, we can study the origin of congenital heart disease and find ways to stop it.”

And second, while the hHO is complex, it is far from perfect. For the team, improving the final organoid is another key avenue of future research. “The organoids are small models of the fetal heart with representative functional and structural features,” Israeli said. “They are, however, not as perfect as a human heart yet. That is something we are working toward.”

 

READ
New Cancer "Vaccine" wipes out cancer in mice, human trials next

 

Aguirre and team are excited about the wide-ranging applicability of these miniature hearts. They enable an unprecedented ability to study many other cardiovascular-related diseases — from chemotherapy-induced cardiotoxicity to the effect of diabetes, during pregnancy, on the developing foetal heart.

Source: Biorvix

Related Posts

Leave a comment

Get your FREE! XPU Introduction to Exponential Thinking Course now. No registration, no catches, just awesome knowledge.GET FUTURED
+

Explore More!

Explore 1000's of articles about our exponential future, 1000's of pages of insights, 1000's of videos, and dig into 100's of exponential technologies. Subscribe to get your no-nonsense briefing on all the biggest stories in exponential technology and science.

Awesome! You're now subscribed.

Pin It on Pinterest

Share This